GO
Loading...

An Anti-Competitive Decision?

Monday, 17 Jun 2013 | 7:44 PM ET

The Supreme Court ruled today that the FTC can keep challenging "pay to delay" deals between pharmaceutical companies and generic drugmakers. CNBC Contributor Keith Boykin; Heather Higgins, Independent Women's Voice; and Doug Holtz-Eakin, American Action Forum, discuss.